Dianthus Therapeutics Inc (DNTH)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Simrat RandhawaExec. VP and Head of R&D | -26.53k | 1.90M | Derivative Exercise and Sale | 8.44 - 91.37 | 4.00k | - |
| 2026-05-08 | Ms. Paula SoteropoulosIndependent Director | -599.00 | 46.14k | Derivative Exercise and Sale | 8.44 - 85.47 | 0.00 | - |
| 2026-04-09 | Mr. Ryan SavitzExec. VP, CFO, Chief Business Officer & Treasurer | -8.22k | 591.80k | Derivative Exercise and Sale | 17.88 - 89.84 | 0.00 | - |
| 2026-03-31 | Mr. Ryan SavitzExec. VP, CFO, Chief Business Officer & Treasurer | -114.37k | 8.15M | Derivative Exercise and Sale | 8.44 - 85.54 | 0.00 | - |
| 2026-03-31 | Ms. Paula SoteropoulosIndependent Director | -599.00 | 42.93k | Derivative Exercise and Sale | 8.44 - 80.11 | 0.00 | - |
| 2026-03-24 | Ms. Paula SoteropoulosIndependent Director | -27.59k | 1.92M | Derivative Exercise and Sale | 8.44 - 78.05 | 0.00 | - |
| 2026-03-16 | Mr. Marino GarciaPresident, CEO & Director | 65.29k | 499.97k | Derivative Exercise and Retained Stock | 6.70 - 17.88 | 65.29k | - |
| 2026-03-12 | Dr. Simrat RandhawaExec. VP and Head of R&D | -33.83k | 2.14M | Derivative Exercise and Sale | 8.44 - 81.48 | 0.00 | - |
| 2026-03-12 | Mr. Marino GarciaPresident, CEO & Director | -122.92k | 9.19M | Derivative Exercise and Sale | 6.70 - 85.53 | 0.00 | - |
| 2026-03-12 | Mr. Edward G. CarrSenior VP & CAO | -43.68k | 2.67M | Derivative Exercise and Sale | 17.88 - 85.53 | 0.00 | - |
| 2025-12-04 | Mr. Ryan SavitzExec. VP, CFO, Chief Business Officer & Treasurer | -20.00k | 734.80k | Derivative Exercise and Sale | 8.44 - 45.18 | 0.00 | - |
| 2025-11-21 | Fairmount Funds Management LLC法人 | -1.17M | 46.22M | 売り | 39.50 | 2.14M | -35.38% |
| 2025-11-13 | Dr. Simrat RandhawaExec. VP and Head of R&D | -196.54k | 4.38M | Derivative Exercise and Sale | 8.44 - 38.14 | 4.00k | - |
| 2025-09-11 | Fairmount Funds Management LLC法人 | 600.00k | 19.80M | 買い | 33.00 | 3.31M | 22.16% |
| 2025-09-09 | Mr. Ryan SavitzExec. VP, CFO, Chief Business Officer & Treasurer | -20.00k | 531.20k | Derivative Exercise and Sale | 8.44 - 35.00 | 0.00 | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。